| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |